AI assistant
SYNTARA LIMITED — Director's Dealing 2015
Aug 3, 2015
65830_rns_2015-08-03_975bafca-d48e-4bfb-90ef-7ec967b42584.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity PHARMAXIS LTD ABN 75 082 811 630
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Malcolm John McComas |
|---|---|
| Date of last notice | 27 September 2011 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Date of change | 4 August 2015 |
|---|---|
| No. of securities held prior to change | Ordinary shares held indirectly: 343,793Options over ordinary shares: 40,000Ordinary shares held directly: Nil |
| Class | Options over ordinary shares |
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
| Number acquired | Nil |
|---|---|
| Number disposed | 20,000 options over ordinary shares (lapsed |
| upon expiry) | |
| Value/Consideration | Nil |
| Note: If consideration is non‐cash, provide details and estimated | |
| valuation | |
| No. of securities held after change | Ordinary shares held indirectly: 343,793 |
| Options over ordinary shares: 20,000 | |
| Ordinaryshares held directly: Nil | |
| Nature of change | Lapsing of employee options upon reaching |
| Example: on‐market trade, off‐market trade, exercise of options,issue of securities under dividend reinvestment plan, participation in | expiration date |
| buy‐back |
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | N/A |
|---|---|
| Nature of interest | |
| Name of registered holder | |
| (if issued securities) | |
| Date of change | |
| No. and class of securities to which | |
| interest related prior to change | |
| Note: Details are only required for a contract in | |
| relation to which the interest has changed | |
| Interest acquired | |
| Interest disposed | |
| Value/Consideration | |
| Note: If consideration is non‐cash, provide details | |
| and an estimated valuation |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011
Appendix 3Y Change of Director’s Interest Notice
Interest after change Part 3 –[+] Closed period Were the interests in the securities or contracts detailed above n/a traded during a[+] closed period where prior written clearance was required? If so, was prior written clearance provided to allow the trade to n/a proceed during this period? If prior written clearance was provided, on what date was this n/a provided?
- See chapter 19 for defined terms.
01/01/2011 Appendix 3Y Page 3